FFA
MBX

Farther Finance Advisors’s MBX Biosciences MBX Stock Holding History

Farther Finance Advisors’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$497 Hold
9
– – ﹤0.01% 5538
2026
Q1 		$291 Sell
9
-1
-10% -$34 ﹤0.01% 5376
2025
Q4 		$315 Sell
10
-318
-97% -$7.72K ﹤0.01% 5127
2025
Q3 		$5.74K Buy
+328
New +$4.38K ﹤0.01% 3698

Other funds holding MBX

AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's MBX Position: Q2 2026 in Review

Farther Finance Advisors held its MBX Biosciences (MBX) position steady in Q2 2026 at 9 shares worth $497. The position accounts for ﹤0.01% of the portfolio, ranked #5538.

Farther Finance Advisors first reported a position in MBX in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.74K in Q3 2025. 5 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Farther Finance Advisors held 9 shares of MBX Biosciences worth $497 as of Q2 2026.
  • Farther Finance Advisors left its MBX Biosciences share count unchanged in Q2 2026.
  • MBX Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5538 holding.
  • Farther Finance Advisors first reported a position in MBX Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Farther Finance Advisors's MBX Biosciences position peaked at $5.74K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.